With indexes near all time highs, lots of stocks and ETFs are looking good, at least on a short-term basis. But what about longer-term investments? Here is the technical outlook of the top performing ETFs over the last five years, but I've added in a few additional criteria so the funds are more likely to be "investment worthy." The first criteria is an expense ratio below 0.5%, which keeps the cost of owning the fund low. All the ETFs have assets greater than $150M, to avoid the possibility of the fund closing and forcing investors to re-allocate invested funds. A five year time frame was chosen to capture both short and longer performance, and it turns out all these funds have had greater than 13% returns over the time frame. That figure is actually quite impressive considering the massive sell-off that occurred in 2008 and 2009.

SEE: How To Pick The Best ETF

iShares Nasdaq Biotechnology (Nasdaq:IBB) is the top performing fund over the last five years, given the criteria. According to Reuters, it has $3.1B in net assets, a 0.48% expense ratio and a 18.47% return over five years. Despite about a 15% pullback in May and early June 2013, the ETF looks to be on the recovery path and the uptrend remains in tact. Technical projections place a target near $203, or about 14% higher from the current $178.40 level. In terms of risk, a drop back below $169 signals a further decline, but buying opportunities exist all the way down to $134. Below $134 though, the uptrend is unlikely to resume and I wouldn't expect to see new highs anytime soon.

iShares Dow Jones US Pharmaceuticals (NYSE:IHE) has $458.6M in net assets, a 0.47% expense ratio and a 17.88% five-year return. Over the last two years, getting into the fund at a "cheap" price has been nearly impossible as it continues to move higher, with pullbacks of more than 10% being exceedingly rare. The target for this ETF is $110, so I do think there is still more room to the upside. A drop below $98.83 (the June 6 low) means a further price slide is likely. From a longer-term perspective though, the fund is a buy all the way down to $84. If the price drops below $84, a downtrend is already likely underway though.

SEE: An Inside Look At ETF Construction

Vangard Consumer Discretionary (NYSE:VCR) has $832M in net assets, an expense ratio of 0.14% and a five-year return of 14.48%. From a low of $52.47 in 2011 to a May 2013 high of $93.39, the uptrend continues to push on. Similar to the other ETFs mentioned prior, pullbacks have been minimal over the last two years, giving few chances to get in at a discounted price. The weekly chart shows a very sharp rise since 2009; this trajectory is unsustainable long term, but I still think a target of of $97 to $98 is possible this year. If the ETF dips below $88.64 (the June 6 low), it warns of a short-term price decline. Down to $81 I see the fund as a buy, but if it drops below that I'd avoid it or get out, since an even more severe decline is likely underway.

Unlike the sector funds discussed above, the Guggenheim S&P 400 Pure Growth (NYSE:RFG) is based more on a strategy. It only invests in S&P MidCap 400 companies with strong growth characteristics. The fund has $635.2M in net assets, a 0.35% expense ratio and a 13.06% five-year return. The target for the fund is $114 to $115. Price drops below $101, $97, $90 or $86 provide short-term warnings that further declines are underway. Due to the strong uptrend though, as long as the price remains above $81 this ETF is providing buying opportunities. Take a step back if a breach of $81 occurs, as downside risk becomes too great to warrant buying into a severely declining market.

SEE: Interpreting Support And Resistance Zones

The Bottom Line
With ETFs, fancy isn't necessarily better. These four funds offer low expense ratios and have been solid performers. When the market is rising, getting into an ETF such as a sector fund is a simple way to attain a basket of stocks that capitalize on market conditions. There is always the possibility of a correction or a big slide. Corrections represent buying opportunities in the uptrend, but if that correction drops too far, it warns that a downtrend is likely underway.

Charts courtesy of stockcharts.com

At the time of writing, Cory Mitchell did not own any shares in any company mentioned in this article.

Related Articles
  1. Investing

    The Three Things Most Good Stocks Have In Common

    Uncover the three things most good stocks have in common: performance, profitability and value.
  2. Options & Futures

    A Guide To Investing In Consumer Staples

    These companies may not be flashy but they offer investors structure and diversification.
  3. Options & Futures

    Going All-In: Comparing Investing And Gambling

    People often compare stocks to gambling, but how close are they really?
  4. Chart Advisor

    Pay Attention To These Stock Patterns Playing Out

    The stocks are all moving different types of patterns. A breakout could signal a major price move in the trending direction, or it could reverse the trend.
  5. Chart Advisor

    Now Could Be The Time To Buy IPOs

    There has been lots of hype around the IPO market lately. We'll take a look at whether now is the time to buy.
  6. Chart Advisor

    Copper Continues Its Descent

    Copper prices have been under pressure lately and based on these charts it doesn't seem that it will reverse any time soon.
  7. Technical Indicators

    Using Pivot Points For Predictions

    Learn one of the most common methods of finding support and resistance levels.
  8. Mutual Funds & ETFs

    Buying Vanguard Mutual Funds Vs. ETFs

    Learn about the differences between Vanguard's mutual fund and ETF products, and discover which may be more appropriate for investors.
  9. Mutual Funds & ETFs

    ETFs Vs. Mutual Funds: Choosing For Your Retirement

    Learn about the difference between using mutual funds versus ETFs for retirement, including which investment strategies and goals are best served by each.
  10. Mutual Funds & ETFs

    How to Reinvest Dividends from ETFs

    Learn about reinvesting ETF dividends, including the benefits and drawbacks of dividend reinvestment plans (DRIPs) and manual reinvestment.
  1. Should mutual funds be subject to more regulation?

    Mutual funds, when compared to other types of pooled investments such as hedge funds, have very strict regulations. In fact, ... Read Full Answer >>
  2. Do ETFs pay capital gains?

    Exchange-traded funds (ETFs) can generate capital gains that are transferred to shareholders, typically once a year, triggering ... Read Full Answer >>
  3. How do real estate hedge funds work?

    A hedge fund is a type of investment vehicle and business structure that aggregates capital from multiple investors and invests ... Read Full Answer >>
  4. Are Vanguard ETFs commission-free?

    While some Vanguard exchange-traded funds (ETFs) are available commission-free from third-party brokers, a large portion ... Read Full Answer >>
  5. Do Vanguard ETFs require a minimum investment?

    Vanguard completely waives any U.S. dollar minimum amounts to buy its exchange-traded funds (ETFs), and the minimum ETF investment ... Read Full Answer >>
  6. Can mutual fund expense ratios be negative?

    Mutual fund expense ratios cannot be negative. An expense ratio is the sum total of all fees charged by an asset management ... Read Full Answer >>

You May Also Like

Trading Center